Aura Biosciences, Inc. - AURA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A Advent Life Sciences LLP 3.26% 2,023,857 View
Feb 17, 2026 SCHEDULE 13G/A Advent Life Sciences Fund I LP 3.26% 2,023,857 View
Feb 17, 2026 SCHEDULE 13G/A Rajesh Parekh, Ph.D. 3.34% 2,071,857 View
Feb 17, 2026 SCHEDULE 13G/A Advent Life Sciences Fund III LP 3.26% 2,023,857 View
Feb 17, 2026 SCHEDULE 13G/A ALS III Carry and Co-Invest LP 3.26% 2,023,857 View
Feb 17, 2026 SCHEDULE 13G/A Advent-Harrington Impact Fund LP 3.26% 2,023,857 View
Feb 13, 2026 SCHEDULE 13G/A Frazier Life Sciences Public Fund, L.P. 6.3% 4,032,060 View
Feb 13, 2026 SCHEDULE 13G/A FHMLSP, L.P. 6.3% 4,032,060 View
Feb 13, 2026 SCHEDULE 13G/A FHMLSP, L.L.C. 6.3% 4,032,060 View
Feb 13, 2026 SCHEDULE 13G/A Frazier Life Sciences X, L.P. 0.2% 128,520 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS X, L.P. 0.2% 128,520 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS X, L.L.C. 0.2% 128,520 View
Feb 13, 2026 SCHEDULE 13G/A Frazier Life Sciences XI, L.P. 0.5% 342,210 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS XI, L.P. 0.5% 342,210 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS XI, L.L.C. 0.5% 342,210 View
Feb 13, 2026 SCHEDULE 13G/A Frazier Life Sciences XII, L.P. 0.9% 597,210 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS XII, L.P. 0.9% 597,210 View
Feb 13, 2026 SCHEDULE 13G/A FHMLS XII, L.L.C. 0.9% 597,210 View
Feb 13, 2026 SCHEDULE 13G/A James N. Topper 0.2% 128,520 View
Feb 13, 2026 SCHEDULE 13G/A Patrick J. Heron 0.2% 128,520 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.